News & Updates

Vaginal swabs better at spotting STIs than urinalysis

03 Apr 2023 by

Contrary to practice, vaginal swabs are more effective than urine analysis in detecting certain types of sexually transmitted infections (STIs) as shown in a meta-analysis.

Vaginal swabs better at spotting STIs than urinalysis

03 Apr 2023

Original New Drug Application Approvals by US FDA (16-31 March 2023)

31 Mar 2023

New drug applications approved by US FDA as of 16-31 March 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2023)

31 Mar 2023

Ceftolozane/tazobactam safe, effective in complicated UTI

30 Mar 2023 by

Combination therapy with ceftolozane and tazobactam demonstrates a favourable safety profile in children with complicated urinary tract infection (cUTI) similar to that of meropenem and to the previously reported safety profile in adults with cUTI, a study has shown.

Ceftolozane/tazobactam safe, effective in complicated UTI

30 Mar 2023

Low-concentration atropine eye drops may reduce myopia incidence in high-risk children

30 Mar 2023 by

Researchers from the Chinese University of Hong Kong (CUHK) have conducted the world’s first study to show that nightly use of low-concentration (0.05 percent) atropine eye drops may reduce the incidence of myopia in high-risk children.

Low-concentration atropine eye drops may reduce myopia incidence in high-risk children

30 Mar 2023

Acetaminophen use during pregnancy poses no risk of adverse cognitive effects in babies

28 Mar 2023

Children born to mothers who used acetaminophen during pregnancy do not appear to have poor cognitive development at 4 years of age, as shown in a study.

Acetaminophen use during pregnancy poses no risk of adverse cognitive effects in babies

28 Mar 2023

Women, minorities remain underrepresented in paediatric cardiology

28 Mar 2023

The presence of women in paediatric cardiology remains inadequate, while that of underrepresented minorities in medicine (URMM) is very limited, reveals a recent study.

Women, minorities remain underrepresented in paediatric cardiology

28 Mar 2023

Oral, on-the-skin immunotherapies show promise against peanut allergy in children

27 Mar 2023 by

Children who are allergic to peanuts may benefit from two immunotherapies, one oral and another epicutaneous or on-the-skin, which have demonstrated safety and efficacy in separate studies presented at the recent AAAAI 2023.

Oral, on-the-skin immunotherapies show promise against peanut allergy in children

27 Mar 2023

G-POEM safe, effective for infants with CHPS

27 Mar 2023

Treatment with the minimally invasive gastric peroral endoscopic pyloromyotomy (G-POEM) is not only safe and feasible but also effective for infants with congenital hypertrophic pyloric stenosis (CHPS), according to a recent study, noting acceptable clinical response in the short term.

G-POEM safe, effective for infants with CHPS

27 Mar 2023

VANGUARD sets the stage for a novel biologic in HAE

27 Mar 2023 by

Monthly injections of the investigational biologic garadacimab substantially reduced the mean attack rate in patients with hereditary angioedema (HAE) in the phase III VANGUARD trial.

VANGUARD sets the stage for a novel biologic in HAE

27 Mar 2023

Maternal Crohn’s disease ups risk of infection in offspring

26 Mar 2023

Offspring born to mothers with Crohn’s disease (CD), but not ulcerative colitis, are at higher risk of infection, suggests a study. This association is partly mediated by adverse birth outcomes and antitumour necrosis factor α (anti-TNFα) agents.

Maternal Crohn’s disease ups risk of infection in offspring

26 Mar 2023

News & Updates

Filter by Specialty:

Specialty:

Vaginal swabs better at spotting STIs than urinalysis

Vaginal swabs better at spotting STIs than urinalysis

Original New Drug Application Approvals by US FDA (16-31 March 2023)

Original New Drug Application Approvals by US FDA (16-31 March 2023)

Ceftolozane/tazobactam safe, effective in complicated UTI

Ceftolozane/tazobactam safe, effective in complicated UTI

Low-concentration atropine eye drops may reduce myopia incidence in high-risk children

Low-concentration atropine eye drops may reduce myopia incidence in high-risk children

Acetaminophen use during pregnancy poses no risk of adverse cognitive effects in babies

Acetaminophen use during pregnancy poses no risk of adverse cognitive effects in babies

Women, minorities remain underrepresented in paediatric cardiology

Women, minorities remain underrepresented in paediatric cardiology

Oral, on-the-skin immunotherapies show promise against peanut allergy in children

Oral, on-the-skin immunotherapies show promise against peanut allergy in children

G-POEM safe, effective for infants with CHPS

G-POEM safe, effective for infants with CHPS

VANGUARD sets the stage for a novel biologic in HAE

VANGUARD sets the stage for a novel biologic in HAE

Maternal Crohn’s disease ups risk of infection in offspring

Maternal Crohn’s disease ups risk of infection in offspring